Express Scripts Holding Company (ESRX) Shares Bought by Cornerstone Capital Management Holdings LLC.

Cornerstone Capital Management Holdings LLC. boosted its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 67.7% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 223,408 shares of the company’s stock after acquiring an additional 90,165 shares during the quarter. Cornerstone Capital Management Holdings LLC.’s holdings in Express Scripts were worth $14,145,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Dodge & Cox lifted its holdings in Express Scripts by 25.7% in the 2nd quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares in the last quarter. Pzena Investment Management LLC purchased a new position in shares of Express Scripts during the 2nd quarter worth $181,234,000. Baupost Group LLC MA purchased a new position in shares of Express Scripts during the 1st quarter worth $80,978,000. Northern Trust Corp raised its holdings in shares of Express Scripts by 12.2% during the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock worth $706,629,000 after acquiring an additional 1,206,980 shares during the period. Finally, Ameriprise Financial Inc. raised its holdings in shares of Express Scripts by 23.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock worth $331,374,000 after acquiring an additional 996,816 shares during the period. 88.44% of the stock is currently owned by hedge funds and other institutional investors.

Express Scripts Holding Company (ESRX) opened at $68.15 on Monday. The company has a market capitalization of $38,600.00, a PE ratio of 9.96, a PEG ratio of 1.01 and a beta of 0.88. Express Scripts Holding Company has a 52-week low of $55.80 and a 52-week high of $73.52. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.61 and a current ratio of 0.73.

Express Scripts (NASDAQ:ESRX) last posted its earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the consensus estimate of $1.90. The firm had revenue of $24.68 billion during the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The firm’s revenue was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.74 earnings per share. research analysts predict that Express Scripts Holding Company will post 7.01 EPS for the current year.

In other Express Scripts news, VP Phyllis S. Anderson sold 643 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Timothy C. Wentworth acquired 8,000 shares of Express Scripts stock in a transaction on Tuesday, October 31st. The stock was purchased at an average price of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is owned by insiders.

Several research analysts have recently commented on ESRX shares. Jefferies Group set a $72.00 price target on Express Scripts and gave the stock a “buy” rating in a report on Tuesday, August 29th. Robert W. Baird reiterated a “hold” rating and set a $56.00 price target on shares of Express Scripts in a report on Friday, September 1st. ValuEngine lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Royal Bank Of Canada assumed coverage on shares of Express Scripts in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 price objective on the stock. Finally, UBS lowered shares of Express Scripts from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Six equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Express Scripts has a consensus rating of “Hold” and an average price target of $70.67.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/11/express-scripts-holding-company-esrx-shares-bought-by-cornerstone-capital-management-holdings-llc.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply